These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

8621 related articles for article (PubMed ID: 11062730)

  • 1. Cachexia induction by EL-4 lymphoma in mice and possible involvement of impaired lipoprotein lipase activity.
    Tsujimoto S; Kawamura I; Inami M; Lacey E; Nishigaki F; Naoe Y; Manda T; Goto T
    Anticancer Res; 2000; 20(5A):3111-6. PubMed ID: 11062730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of lipoprotein lipase and inhibition of B16 melanoma-induced cachexia in mice by ponalrestat, an aldose reductase inhibitor.
    Kawamura I; Yamamoto N; Sakai F; Yamazaki H; Naoe Y; Inami M; Manda T; Shimomura K
    Anticancer Res; 1999; 19(1A):341-8. PubMed ID: 10226565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of lipoprotein lipase activators bezafibrate and NO-1886, on B16 melanoma-induced cachexia in mice.
    Kawamura I; Yamamoto N; Sakai F; Yamazaki H; Goto T
    Anticancer Res; 1999; 19(5B):4099-103. PubMed ID: 10628360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ponalrestat, an aldose reductase inhibitor, inhibits cachexia syndrome in nude mice bearing human melanomas G361 and SEKI.
    Kawamura I; Lacey E; Inami M; Nishigaki F; Naoe Y; Tsujimoto S; Manda T; Goto T
    Anticancer Res; 1999; 19(5B):4091-7. PubMed ID: 10628359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma interleukin-6 is not a mediator of changes in lipoprotein lipase activity in cancer patients.
    Nomura K; Noguchi Y; Yoshikawa T; Kondo J
    Hepatogastroenterology; 1997; 44(17):1519-26. PubMed ID: 9356883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipolytic and lipoprotein lipase (LPL)-inhibiting activities produced by a human lung cancer cell line responsible for cachexia induction.
    Nara-Ashizawa N; Akiyama Y; Maruyama K; Tsukada T; Yamaguchi K
    Anticancer Res; 2001; 21(5):3381-7. PubMed ID: 11848498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3-L1 adipocytes: a possible role for interleukin 6 in cancer cachexia.
    Greenberg AS; Nordan RP; McIntosh J; Calvo JC; Scow RO; Jablons D
    Cancer Res; 1992 Aug; 52(15):4113-6. PubMed ID: 1638523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid metabolism in cachectic tumor-bearing rats at different stages of tumor growth.
    Obeid OA; Emery PW
    Nutr Cancer; 1993; 19(1):87-98. PubMed ID: 8446517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ponalrestat, an aldose reductase inhibitor, inhibits cachexia syndrome induced by colon26 adenocarcinoma in mice.
    Kawamura I; Lacey E; Yamamoto N; Sakai F; Takeshita S; Inami M; Nishigaki F; Naoe Y; Tsujimoto S; Manda T; Shimomura K; Goto T
    Anticancer Res; 1999; 19(5B):4105-11. PubMed ID: 10628361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour inoculation site-dependent induction of cachexia in mice bearing colon 26 carcinoma.
    Matsumoto T; Fujimoto-Ouchi K; Tamura S; Tanaka Y; Ishitsuka H
    Br J Cancer; 1999 Feb; 79(5-6):764-9. PubMed ID: 10070867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin attenuates cachectic events and decreases production of interleukin-6, a cachexia-inducing cytokine.
    Kanzaki M; Soda K; Gin PT; Kai T; Konishi F; Kawakami M
    Cytokine; 2005 Dec; 32(5):234-9. PubMed ID: 16338141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lipoprotein lipase-mediated myopathy: implications for lipid metabolism and atherogenesis].
    Merkel M; Radner H; Greten H
    Med Klin (Munich); 2003 Dec; 98(12):679-84. PubMed ID: 14685668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of cancer cachexia by a novel nuclear factor {kappa}B inhibitor in prostate cancer.
    Kuroda K; Horiguchi Y; Nakashima J; Kikuchi E; Kanao K; Miyajima A; Ohigashi T; Umezawa K; Murai M
    Clin Cancer Res; 2005 Aug; 11(15):5590-4. PubMed ID: 16061877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of NF-kappa B in cancer cachexia].
    Zhou W; Jiang ZW; Jiang J; Li N; Li JS
    Zhonghua Wai Ke Za Zhi; 2004 Jun; 42(11):683-6. PubMed ID: 15329260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of carcass weight loss in cachexia in rats bearing Leydig cell tumor by the novel compound NO-1886, a lipoprotein lipase activator.
    Ohara M; Tsutsumi K; Ohsawa N
    Metabolism; 1998 Jan; 47(1):101-5. PubMed ID: 9440486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of lipoprotein lipase in 3T3-L1 cells by a mediator produced by SEKI melanoma, a cachexia-inducing human melanoma cell line.
    Kawakami M; Kondo Y; Imai Y; Hashiguchi M; Ogawa H; Hiragun A; Aotsuka S; Shibata S; Oda T; Murase T
    J Biochem; 1991 Jan; 109(1):78-82. PubMed ID: 2016276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum sialyltransferase and liver catalase activity in cachectic nude mice bearing a human malignant melanoma.
    Kondo Y; Sato K; Ueyama Y; Ohsawa N
    Cancer Res; 1981 Jul; 41(7):2912-6. PubMed ID: 7248951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin promotes induction of lipoprotein lipase in skeletal muscle through activation of adenosine monophosphate-activated protein kinase.
    Ohira M; Miyashita Y; Murano T; Watanabe F; Shirai K
    Metabolism; 2009 Oct; 58(10):1408-14. PubMed ID: 19570550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FR177391, a new anti-hyperlipidemic agent from Serratia. II. Pharmacological activity of FR177391.
    Inami M; Kawamura I; Tsujimoto S; Yasuno T; Lacey E; Hirosumi J; Takakura S; Nishigaki F; Naoe Y; Manda T; Mutoh S
    J Antibiot (Tokyo); 2005 Oct; 58(10):640-7. PubMed ID: 16392680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of decreased lipoprotein lipase activity in the tumor-bearing state by the antihyperlipidemic drug bezafibrate.
    Nomura K; Noguchi Y; Matsumoto A
    Surg Today; 1996; 26(2):89-94. PubMed ID: 8919277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 432.